Evolution of the Humoral Response during HCV Infection

Aasa-Chapman, 2005, Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection, Journal of Virology, 79, 2823, 10.1128/JVI.79.5.2823-2830.2005 Afdhal, 2013, The new paradigm of hepatitis C therapy: Integration of oral therapies into best practices, Journal of Viral Hepatitis, 20, 745, 10.1111/jvh.12173 Agnello, 1999, Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor, Proceedings of the National Academy of Sciences of the United States of America, 96, 12766, 10.1073/pnas.96.22.12766 Alam, 2007, The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes, Journal of Immunology, 178, 4424, 10.4049/jimmunol.178.7.4424 Alam, 2009, Role of HIV membrane in neutralization by two broadly neutralizing antibodies, Proceedings of the National Academy of Sciences of the United States of America, 106, 20234, 10.1073/pnas.0908713106 Alcena, 2013, 9G4+ antibodies isolated from HIV-infected patients neutralize HIV-1 and have distinct autoreactivity profiles, PLoS One, 8, e85098, 10.1371/journal.pone.0085098 Allander, 2000, Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81, The Journal of General Virology, 81, 2451, 10.1099/0022-1317-81-10-2451 Alter, 2010, The humoral response to HIV-1: New insights, renewed focus, Journal of Infectious Diseases, 202, S315, 10.1086/655654 Asmal, 2011, Antibody-dependent cell-mediated viral inhibition emerges after simian immunodeficiency virus SIVmac251 infection of rhesus monkeys coincident with gp140-binding antibodies and is effective against neutralization-resistant viruses, Journal of Virology, 85, 5465, 10.1128/JVI.00313-11 Astronomo, 2010, Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds, Chemistry and Biology, 17, 357, 10.1016/j.chembiol.2010.03.012 Aucouturier, 1986, Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome, Clinical and Experimental Immunology, 63, 234 Averhoff, 2012, Global burden of hepatitis C: Considerations for healthcare providers in the United States, Clinical Infectious Diseases, 55, S10, 10.1093/cid/cis361 Balazs, 2012, Antibody-based protection against HIV infection by vectored immunoprophylaxis, Nature, 481, 81, 10.1038/nature10660 Barnes, 2012, Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man, Science Translational Medicine, 4, 115ra111, 10.1126/scitranslmed.3003155 Bartenschlager, 2013, The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection, Nature Reviews. Microbiology, 11, 482, 10.1038/nrmicro3046 Barth, 2003, Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate, The Journal of Biological Chemistry, 278, 41003, 10.1074/jbc.M302267200 Bartosch, 2003, In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences of the United States of America, 100, 14199, 10.1073/pnas.2335981100 Bartosch, 2003, Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes, The Journal of Experimental Medicine, 197, 633, 10.1084/jem.20021756 Baum, 1996, HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression, Journal of Immunology, 157, 2168 Baumgarth, 2011, The double life of a B-1 cell: Self-reactivity selects for protective effector functions, Nature Reviews. Immunology, 11, 34, 10.1038/nri2901 Baumgarth, 1999, Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system, Proceedings of the National Academy of Sciences of the United States of America, 96, 2250, 10.1073/pnas.96.5.2250 Berberian, 1993, Immunoglobulin VH3 gene products: Natural ligands for HIV gp120, Science, 261, 1588, 10.1126/science.7690497 Berkowska, 2011, Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways, Blood, 118, 2150, 10.1182/blood-2011-04-345579 Bhat, 2002, VH4-34 encoded antibody in systemic lupus erythematosus: Effect of isotype, Journal of Rheumatology, 29, 2114 Bjoro, 1994, Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin, The New England Journal of Medicine, 331, 1607, 10.1056/NEJM199412153312402 Bonsignori, 2011, Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors, Journal of Virology, 85, 9998, 10.1128/JVI.05045-11 Bonsignori, 2012, Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: Implications for vaccine design, Journal of Virology, 86, 4688, 10.1128/JVI.07163-11 Bonsignori, 2012, Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family, Journal of Virology, 86, 11521, 10.1128/JVI.01023-12 Borrow, 1997, Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus, Nature Medicine, 3, 205, 10.1038/nm0297-205 Breden, 2011, Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease, PLoS One, 6, e16857, 10.1371/journal.pone.0016857 Brenchley, 2004, CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract, Journal of Experimental Medicine, 200, 749, 10.1084/jem.20040874 Brimacombe, 2011, Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission, Journal of Virology, 85, 596, 10.1128/JVI.01592-10 Briney, 2012, Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes, PLoS One, 7, e36750, 10.1371/journal.pone.0036750 Briney, 2012, Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire, Immunology, 137, 56, 10.1111/j.1365-2567.2012.03605.x Broering, 2009, Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus, Journal of Virology, 83, 12473, 10.1128/JVI.01138-09 Burton, 1994, Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody, Science, 266, 1024, 10.1126/science.7973652 Cagigi, 2009, CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection, PLoS One, 4, e5427, 10.1371/journal.pone.0005427 Callendret, 2014, T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee, Hepatology (Baltimore, Md.), 60, 1531, 10.1002/hep.27278 Capone, 2014, Cytokinome profile evaluation in patients with hepatitis C virus infection, World Journal of Gastroenterology, 20, 9261 Cappione, 2005, Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus, The Journal of Clinical Investigation, 115, 3205, 10.1172/JCI24179 Carbonari, 2005, Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis, The Journal of Immunology, 174, 6532, 10.4049/jimmunol.174.10.6532 Carrington, 2012, Immunogenetics of spontaneous control of HIV, Annual Review of Medicine, 63, 131, 10.1146/annurev-med-062909-130018 Castillo, 2006, Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment, Clinical Infectious Diseases, 43, 1277, 10.1086/508198 Charles, 2011, Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset, Blood, 117, 5425, 10.1182/blood-2010-10-312942 Charles, 2008, Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia, Blood, 111, 1344, 10.1182/blood-2007-07-101717 Chen, 1999, Limited humoral immunity in hepatitis C virus infection, Gastroenterology, 116, 135, 10.1016/S0016-5085(99)70237-4 Chen, 2013, Persistence of hepatitis C virus during and after otherwise clinically successful treatment of chronic hepatitis C with standard pegylated interferon alpha-2b and ribavirin therapy, PLoS One, 8, e80078, 10.1371/journal.pone.0080078 Choo, 1989, Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome, Science, 244, 359, 10.1126/science.2523562 Cooper, 1999, Analysis of a successful immune response against hepatitis C virus, Immunity, 10, 439, 10.1016/S1074-7613(00)80044-8 Cortez, 2015, Beyond interferon: Rationale and prospects for newer treatment paradigms for chronic hepatitis C, Therapeutic Advances in Chronic Disease, 6, 4, 10.1177/2040622314551934 Coutelier, 1994, Involvement of CD4+ cells in lymphocytic choriomeningitis virus-induced autoimmune anaemia and hypergammaglobulinaemia, Journal of Autoimmunity, 7, 589, 10.1006/jaut.1994.1043 Covens, 2013, Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype, Blood, 121, 5176, 10.1182/blood-2012-12-471953 Cox, 2005, Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C, Hepatology, 42, 104, 10.1002/hep.20749 Culton, 2007, Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss, Journal of Clinical Immunology, 27, 53, 10.1007/s10875-006-9051-1 Culton, 2006, Early preplasma cells define a tolerance checkpoint for autoreactive B cells, Journal of Immunology, 176, 790, 10.4049/jimmunol.176.2.790 Day, 2006, PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, 443, 350, 10.1038/nature05115 De Milito, 2004, Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection, Blood, 103, 2180, 10.1182/blood-2003-07-2375 De Re, 2000, Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia, Blood, 96, 3578, 10.1182/blood.V96.10.3578 Deshmukh, 2003, Mechanisms of autoantibody diversification to SLE-related autoantigens, Annals of the New York Academy of Sciences, 987, 91, 10.1111/j.1749-6632.2003.tb06036.x Di Lorenzo, 2011, Hepatitis C virus evasion mechanisms from neutralizing antibodies, Viruses, 3, 2280, 10.3390/v3112280 Doi, 2014, Peripheral CD27-CD21-B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosis, Clinical Immunology, 150, 184, 10.1016/j.clim.2013.12.001 Doores, 2013, 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies, Journal of Virology, 87, 2234, 10.1128/JVI.02820-12 Doria-Rose, 2009, Antibody-secreting B cells in HIV infection, Current Opinion in HIV and AIDS, 4, 426, 10.1097/COH.0b013e32832d9fac Doria-Rose, 2010, Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables, Journal of Virology, 84, 1631, 10.1128/JVI.01482-09 Dowd, 2009, Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus, Gastroenterology, 136, 2377, 10.1053/j.gastro.2009.02.080 Doyle-Cooper, 2013, Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10, Journal of Immunology, 191, 3186, 10.4049/jimmunol.1301285 Evans, 2007, Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, 446, 801, 10.1038/nature05654 Fairfax, 2008, Plasma cell development: From B-cell subsets to long-term survival niches, Seminars in Immunology, 20, 49, 10.1016/j.smim.2007.12.002 Falkowska, 2007, Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization, Journal of Virology, 81, 8072, 10.1128/JVI.00459-07 Farci, 1994, Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization, Proceedings of the National Academy of Sciences of the United States of America, 91, 7792, 10.1073/pnas.91.16.7792 Farci, 1991, A long-term study of hepatitis C virus replication in non-A, non-B hepatitis, The New England Journal of Medicine, 325, 98, 10.1056/NEJM199107113250205 Fazilleau, 2007, Local development of effector and memory T helper cells, Current Opinion in Immunology, 19, 259, 10.1016/j.coi.2007.04.003 Feng, 2012, Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells, Journal of Gastroenterology, 47, 1048, 10.1007/s00535-012-0568-1 Ferri, 2015, Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer, World Journal of Hepatology, 7, 327, 10.4254/wjh.v7.i3.327 Fiebig, 2003, Dynamics of HIV viremia and antibody seroconversion in plasma donors: Implications for diagnosis and staging of primary HIV infection, AIDS, 17, 1871, 10.1097/00002030-200309050-00005 Forthal, 2005, Interactions between natural killer cells and antibody Fc result in enhanced antibody neutralization of human immunodeficiency virus type 1, Journal of Virology, 79, 2042, 10.1128/JVI.79.4.2042-2049.2005 Frey, 2010, Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults, Vaccine, 28, 6367, 10.1016/j.vaccine.2010.06.084 Garson, 1990, Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates, Lancet, 336, 1022, 10.1016/0140-6736(90)92487-3 Gentile, 2013, A novel promising therapeutic option against hepatitis C virus: An oral nucleotide NS5B polymerase inhibitor sofosbuvir, Current Medicinal Chemistry, 20, 3733, 10.2174/09298673113209990178 Georgiev, 2014, Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline, Journal of Immunology, 192, 1100, 10.4049/jimmunol.1302515 Giang, 2012, Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus, Proceedings of the National Academy of Sciences of the United States of America, 109, 6205, 10.1073/pnas.1114927109 Gilbert, 2011, Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: A case study for statistical issues in efficacy trials, Journal of Infectious Diseases, 203, 969, 10.1093/infdis/jiq152 Goffard, 2005, Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins, Journal of Virology, 79, 8400, 10.1128/JVI.79.13.8400-8409.2005 Gomez-Roman, 2005, Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251, Journal of Immunology, 174, 2185, 10.4049/jimmunol.174.4.2185 Goo, 2012, A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection, Journal of Virology, 86, 10857, 10.1128/JVI.01414-12 Goonetilleke, 2009, The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection, Journal of Experimental Medicine, 206, 1253, 10.1084/jem.20090365 Grakoui, 2003, HCV persistence and immune evasion in the absence of memory T cell help, Science, 302, 659, 10.1126/science.1088774 Gray, 2011, Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual, Journal of Virology, 85, 7719, 10.1128/JVI.00563-11 Griffin, 2011, Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70, Journal of Experimental Medicine, 208, 67, 10.1084/jem.20101499 Griffin, 2012, Human CD11b+ B1 cells are not monocytes: A reply to “Gene profiling of CD11b+ and CD11b− B1 cell subsets reveals potential cell sorting artifacts”, Journal of Experimental Medicine, 209, 434, 10.1084/jem.20120403 Haase, 1999, Population biology of HIV-1 infection: Viral and CD4+ T cell demographics and dynamics in lymphatic tissues, Annual Review of Immunology, 17, 625, 10.1146/annurev.immunol.17.1.625 Hadlock, 2000, Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes, Journal of Virology, 74, 10407, 10.1128/JVI.74.22.10407-10416.2000 Hardy, 2001, B cell development pathways, Annual Review of Immunology, 19, 595, 10.1146/annurev.immunol.19.1.595 Haynes, 2005, Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies, Science, 308, 1906, 10.1126/science.1111781 He, 2006, HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors, Journal of Immunology, 176, 3931, 10.4049/jimmunol.176.7.3931 Hoare, 2008, Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection, Hepatology, 48, 1737, 10.1002/hep.22484 Hoofnagle, 2002, Course and outcome of hepatitis C, Hepatology, 36, S21, 10.1002/hep.1840360704 Hsu, 2003, Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proceedings of the National Academy of Sciences of the United States of America, 100, 7271, 10.1073/pnas.0832180100 Huang, 2012, Broad and potent neutralization of HIV-1 by a gp41-specific human antibody, Nature, 491, 406, 10.1038/nature11544 Hunziker, 2003, Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections, Nature Immunology, 4, 343, 10.1038/ni911 Hwang, 2014, IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria, PLoS One, 9, e90725, 10.1371/journal.pone.0090725 Isenberg, 1985, Detection of cross-reactive anti-DNA antibody idiotypes on renal tissue-bound immunoglobulins from lupus patients, The Journal of Clinical Investigation, 76, 287, 10.1172/JCI111959 Ivanovski, 1998, Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas, Blood, 91, 2433, 10.1182/blood.V91.7.2433 Johansson, 2007, Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus, Proceedings of the National Academy of Sciences of the United States of America, 104, 16269, 10.1073/pnas.0705522104 Johnson, 2009, Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys, Nature Medicine, 15, 901, 10.1038/nm.1967 Johnston, 2011, HIV vaccine development—Improving on natural immunity, New England Journal of Medicine, 365, 873, 10.1056/NEJMp1107621 Kardava, 2011, Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors, Journal of Clinical Investigation, 121, 2614, 10.1172/JCI45685 Karray, 1997, Identification of the B cell superantigen-binding site of HIV-1 gp120, Proceedings of the National Academy of Sciences of the United States of America, 94, 1356, 10.1073/pnas.94.4.1356 Kato, 1993, Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus, Journal of Virology, 67, 3923, 10.1128/JVI.67.7.3923-3930.1993 Katze, 2002, Viruses and interferon: A fight for supremacy, Nature Reviews. Immunology, 2, 675, 10.1038/nri888 Keck, 2012, Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate, PLoS Pathogens, 8, e1002653, 10.1371/journal.ppat.1002653 Kenny, 2000, Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors, Journal of Immunology, 164, 4111, 10.4049/jimmunol.164.8.4111 Kirkham, 1994, Antibody structure and the evolution of immunoglobulin V gene segments, Seminars in Immunology, 6, 347, 10.1006/smim.1994.1045 Klein, 2012, Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein, Journal of Experimental Medicine, 209, 1469, 10.1084/jem.20120423 Kobayashi, 2007, Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: A multicenter, retrospective cohort study of 1124 patients, Liver International, 27, 186, 10.1111/j.1478-3231.2006.01406.x Kobie, 2012, 9G4 autoreactivity is increased in HIV-infected patients and correlates with HIV broadly neutralizing serum activity, PLoS One, 7, e35356, 10.1371/journal.pone.0035356 Koelsch, 2007, Mature B cells class switched to IgD are autoreactive in healthy individuals, Journal of Clinical Investigation, 117, 1558, 10.1172/JCI27628 Kondo, 2013, Direct effects of hepatitis C virus on the lymphoid cells, World Journal of Gastroenterology, 19, 7889, 10.3748/wjg.v19.i44.7889 Kong, 2013, Hepatitis C virus E2 envelope glycoprotein core structure, Science, 342, 1090, 10.1126/science.1243876 Krachmarov, 2005, Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade a and clade B v3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking, Journal of Virology, 79, 780, 10.1128/JVI.79.2.780-790.2005 Kruetzmann, 2003, Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen, Journal of Experimental Medicine, 197, 939, 10.1084/jem.20022020 Kurosaki, 1993, Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infection, Hepatology, 18, 1293, 10.1002/hep.1840180602 Kwong, 2011, Rational design of vaccines to elicit broadly neutralizing antibodies to HIV-1, Cold Spring Harbor Perspectives in Medicine, 1, a007278, 10.1101/cshperspect.a007278 Lagging, 1998, Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus, Journal of Virology, 72, 3539, 10.1128/JVI.72.5.3539-3546.1998 Lane, 1983, Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome, New England Journal of Medicine, 309, 453, 10.1056/NEJM198308253090803 Lang Kuhs, 2012, Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected], Molecular Therapy, 20, 669, 10.1038/mt.2011.188 Lapierre, 2011, Structural basis for broad neutralization of hepatitis C virus quasispecies, PLoS One, 6, e26981, 10.1371/journal.pone.0026981 Lavillette, 2005, Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection, Journal of Virology, 79, 6023, 10.1128/JVI.79.10.6023-6034.2005 Law, 2013, A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans, PLoS One, 8, e59776, 10.1371/journal.pone.0059776 Law, 2008, Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge, Nature Medicine, 14, 25, 10.1038/nm1698 Leggat, 2013, Pneumococcal polysaccharide vaccination induces polysaccharide-specific B cells in adult peripheral blood expressing CD19(+)CD20(+)CD3(-)CD70(-)CD27(+)IgM(+)CD43(+)CD5(+)/(-), Vaccine, 31, 4632, 10.1016/j.vaccine.2013.07.030 LeMaoult, 1999, Cellular basis of B cell clonal populations in old mice, The Journal of Immunology, 162, 6384 Levesque, 2009, Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection, PLoS Medicine, 6, e1000107, 10.1371/journal.pmed.1000107 Levy, 2011, Induction and function of type I and III interferon in response to viral infection, Current Opinion in Virology, 1, 476, 10.1016/j.coviro.2011.11.001 Li, 2013, Innate immune responses in hepatitis C virus infection, Seminars in Immunopathology, 35, 53, 10.1007/s00281-012-0332-x Li, 2005, Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells, Nature, 434, 1148, 10.1038/nature03513 Liao, 2013, Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus, Nature, 496, 469, 10.1038/nature12053 Lindenbach, 2005, Complete replication of hepatitis C virus in cell culture, Science, 309, 623, 10.1126/science.1114016 Lindqvist, 2012, Expansion of HIV-specific T follicular helper cells in chronic HIV infection, The Journal of Clinical Investigation, 122, 3271, 10.1172/JCI64314 Loder, 1999, B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals, Journal of Experimental Medicine, 190, 75, 10.1084/jem.190.1.75 Logvinoff, 2004, Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences of the United States of America, 101, 10149, 10.1073/pnas.0403519101 Lopes-Carvalho, 2004, Development and selection of marginal zone B cells, Immunological Reviews, 197, 192, 10.1111/j.0105-2896.2004.0112.x Lu, 2010, Polyvalent AIDS vaccines, Current HIV Research, 8, 622, 10.2174/157016210794088290 Ludewig, 2004, Molecular characterization of virus-induced autoantibody responses, Journal of Experimental Medicine, 200, 637, 10.1084/jem.20040358 Lupberger, 2011, EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy, Nature Medicine, 17, 589, 10.1038/nm.2341 Macagno, 2007, Duration, combination and timing: The signal integration model of dendritic cell activation, Trends in Immunology, 28, 227, 10.1016/j.it.2007.03.008 Major, 2004, Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees, Hepatology, 39, 1709, 10.1002/hep.20239 Makiyama, 2004, Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy, Cancer, 101, 1616, 10.1002/cncr.20537 Manjarrez-Orduno, 2009, B cells and immunological tolerance, Journal of Investigative Dermatology, 129, 278, 10.1038/jid.2008.240 Marasca, 2001, Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma, The American Journal of Pathology, 159, 253, 10.1016/S0002-9440(10)61691-4 Marceau, 2005, LKM1 autoantibodies in chronic hepatitis C infection: A case of molecular mimicry?, Hepatology (Baltimore, Md.), 42, 675, 10.1002/hep.20816 Market, 2003, V(D)J recombination and the evolution of the adaptive immune system, PLoS Biology, 1, E16, 10.1371/journal.pbio.0000016 Martinez-Maza, 2002, B-cell activation and lymphoma in patients with HIV, Current Opinion in Oncology, 14, 528, 10.1097/00001622-200209000-00009 Martinez-Maza, 1987, Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity, Journal of Immunology, 138, 3720 Mattapallil, 2005, Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection, Nature, 434, 1093, 10.1038/nature03501 Mayo, 2003, Extrahepatic manifestations of hepatitis C infection, The American Journal of the Medical Sciences, 325, 135, 10.1097/00000441-200303000-00006 McCaffrey, 2004, N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti-gp41 antibodies, Journal of Virology, 78, 3279, 10.1128/JVI.78.7.3279-3295.2004 Mc Cann, 2005, Antibodies: Can they protect against HIV infection?, Current Drug Targets. Infectious Disorders, 5, 95, 10.2174/1568005054201580 McHeyzer-Williams, 2003, B cells as effectors, Current Opinion in Immunology, 15, 354, 10.1016/S0952-7915(03)00046-3 McHeyzer-Williams, 2005, Antigen-specific memory B cell development, Annual Review of Immunology, 23, 487, 10.1146/annurev.immunol.23.021704.115732 McMichael, 2006, HIV vaccines, Annual Review of Immunology, 24, 227, 10.1146/annurev.immunol.24.021605.090605 McMichael, 2010, The immune response during acute HIV-1 infection: Clues for vaccine development, Nature Reviews. Immunology, 10, 11, 10.1038/nri2674 Meffre, 2001, Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development, The Journal of Clinical Investigation, 108, 879, 10.1172/JCI13051 Meuleman, 2008, Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo, Hepatology, 48, 1761, 10.1002/hep.22547 Meunier, 2008, Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus, Journal of Virology, 82, 966, 10.1128/JVI.01872-07 Micallef, 2006, Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies, Journal of Viral Hepatitis, 13, 34, 10.1111/j.1365-2893.2005.00651.x Mikell, 2011, Characteristics of the earliest cross-neutralizing antibody response to HIV-1, PLoS Pathogens, 7, e1001251, 10.1371/journal.ppat.1001251 Milich, 1987, Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site, Nature, 329, 547, 10.1038/329547a0 Miller, 2010, Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt, Proceedings of the National Academy of Sciences of the United States of America, 107, 14757, 10.1073/pnas.1008877107 Mohd Hanafiah, 2013, Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence, Hepatology, 57, 1333, 10.1002/hep.26141 Moir, 2011, Pathogenic mechanisms of HIV disease, Annual Review of Pathology, 6, 223, 10.1146/annurev-pathol-011110-130254 Moir, 2008, Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals, Journal of Experimental Medicine, 205, 1797, 10.1084/jem.20072683 Moir, 2000, B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells, Journal of Experimental Medicine, 192, 637, 10.1084/jem.192.5.637 Montero, 2012, Neutralizing epitopes in the membrane-proximal external region of HIV-1 gp41 are influenced by the transmembrane domain and the plasma membrane, Journal of Virology, 86, 2930, 10.1128/JVI.06349-11 Moore, 2008, The c3-v4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C infection, Journal of Virology, 82, 1860, 10.1128/JVI.02187-07 Moore, 2011, Potent and broad neutralization of HIV-1 subtype C by plasma antibodies targeting a quaternary epitope including residues in the V2 loop, Journal of Virology, 85, 3128, 10.1128/JVI.02658-10 Morgan, 2010, Outcome of sustained virological responders with histologically advanced chronic hepatitis C, Hepatology, 52, 833, 10.1002/hep.23744 Morin, 2012, Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees, PLoS Pathogens, 8, e1002895, 10.1371/journal.ppat.1002895 Morris, 2011, Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting, PLoS One, 6, e23532, 10.1371/journal.pone.0023532 Morse, 2001, Cells of the marginal zone—Origins, function and neoplasia, Leukemia Research, 25, 169, 10.1016/S0145-2126(00)00107-7 Moser, 2006, Stromal niches, plasma cell differentiation and survival, Current Opinion in Immunology, 18, 265, 10.1016/j.coi.2006.03.004 Mouquet, 2010, Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation, Nature, 467, 591, 10.1038/nature09385 Murakami, 1992, Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice, Nature, 357, 77, 10.1038/357077a0 Murira, A., Henry, K. A., Ahmed, F. K., Klaric, K., Droumeva, R., Kardava, L., et al. (2016). Comparison of humoral immune responses between chronic HIV infection and SLE reveals similar perturbations in B-cell subset distributions and distinct serological profiles. Manuscript in preparation. Muster, 1993, A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1, Journal of Virology, 67, 6642, 10.1128/JVI.67.11.6642-6647.1993 Myers, 2014, Burden of disease and cost of chronic hepatitis C infection in Canada, Canadian Journal of Gastroenterology & Hepatology, 28, 243, 10.1155/2014/317623 Netski, 2005, Humoral immune response in acute hepatitis C virus infection, Clinical Infectious Diseases, 41, 667, 10.1086/432478 Neumann, 1998, Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, Science, 282, 103, 10.1126/science.282.5386.103 Neumann-Haefelin, 2011, Success and failure of virus-specific T cell responses in hepatitis C virus infection, Digestive Diseases, 29, 416, 10.1159/000329807 Okada, 2006, B cell migration and interactions in the early phase of antibody responses, Current Opinion in Immunology, 18, 278, 10.1016/j.coi.2006.02.005 Oracki, 2010, Plasma cell development and survival, Immunological Reviews, 237, 140, 10.1111/j.1600-065X.2010.00940.x Orland, 2001, Acute hepatitis C, Hepatology, 33, 321, 10.1053/jhep.2001.22112 Osburn, 2010, Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection, Gastroenterology, 138, 315, 10.1053/j.gastro.2009.09.017 Osburn, 2014, Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses, Hepatology, 59, 2140, 10.1002/hep.27013 Owsianka, 2005, Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein, Journal of Virology, 79, 11095, 10.1128/JVI.79.17.11095-11104.2005 Owsianka, 2008, Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein, The Journal of General Virology, 89, 653, 10.1099/vir.0.83386-0 Page, 2009, Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection, The Journal of Infectious Diseases, 200, 1216, 10.1086/605947 Pape, 2007, The humoral immune response is initiated in lymph nodes by B cells that acquire soluble antigen directly in the follicles, Immunity, 26, 491, 10.1016/j.immuni.2007.02.011 Park, 2014, Immune responses to HCV and other hepatitis viruses, Immunity, 40, 13, 10.1016/j.immuni.2013.12.010 Paus, 2006, Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation, Journal of Experimental Medicine, 203, 1081, 10.1084/jem.20060087 Perotti, 2008, Identification of a broadly cross-reacting and neutralizing human monoclonal antibody directed against the hepatitis C virus E2 protein, Journal of Virology, 82, 1047, 10.1128/JVI.01986-07 Pestka, 2007, Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C, Proceedings of the National Academy of Sciences of the United States of America, 104, 6025, 10.1073/pnas.0607026104 Pham, 2012, Hepatitis C virus persistence after sustained virological response to antiviral therapy in patients with or without past exposure to hepatitis B virus, Journal of Viral Hepatitis, 19, 103, 10.1111/j.1365-2893.2011.01442.x Phan, 2005, Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen, Journal of Immunology, 174, 4567, 10.4049/jimmunol.174.8.4567 Pietschmann, 2006, Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proceedings of the National Academy of Sciences of the United States of America, 103, 7408, 10.1073/pnas.0504877103 Pileri, 1998, Binding of hepatitis C virus to CD81, Science, 282, 938, 10.1126/science.282.5390.938 Pillai, 2009, The follicular versus marginal zone B lymphocyte cell fate decision, Nature Reviews. Immunology, 9, 767, 10.1038/nri2656 Pinter, 2004, The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection, Journal of Virology, 78, 5205, 10.1128/JVI.78.10.5205-5215.2004 Ploss, 2009, Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, 457, 882, 10.1038/nature07684 Powell, 2001, Epitope spreading: Protection from pathogens, but propagation of autoimmunity?, Clinical and Experimental Dermatology, 26, 427, 10.1046/j.1365-2230.2001.00852.x Pugh-Bernard, 2001, Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance, The Journal of Clinical Investigation, 108, 1061, 10.1172/JCI200112462 Qiao, 2006, Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells, Nature Immunology, 7, 302, 10.1038/ni1302 Quinn, 2001, The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis, Blood, 98, 3745, 10.1182/blood.V98.13.3745 Racanelli, 2011, Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections, PLoS One, 6, e25606, 10.1371/journal.pone.0025606 Racanelli, 2003, Hepatitis C virus infection: When silence is deception, Trends in Immunology, 24, 456, 10.1016/S1471-4906(03)00178-9 Radkowski, 2005, Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C, Hepatology, 41, 106, 10.1002/hep.20518 Raghuraman, 2012, Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion, The Journal of Infectious Diseases, 205, 763, 10.1093/infdis/jir835 Randall, 2008, Interferons and viruses: An interplay between induction, signalling, antiviral responses and virus countermeasures, The Journal of General Virology, 89, 1, 10.1099/vir.0.83391-0 Rauch, 2010, Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study, Gastroenterology, 138, 1338, 10.1053/j.gastro.2009.12.056 Razavi, 2013, Chronic hepatitis C virus (HCV) disease burden and cost in the United States, Hepatology, 57, 2164, 10.1002/hep.26218 Rehermann, 2009, Hepatitis C virus versus innate and adaptive immune responses: A tale of coevolution and coexistence, The Journal of Clinical Investigation, 119, 1745, 10.1172/JCI39133 Rehermann, 2005, Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews. Immunology, 5, 215, 10.1038/nri1573 Reitter, 1998, A role for carbohydrates in immune evasion in AIDS, Nature Medicine, 4, 679, 10.1038/nm0698-679 Rerks-Ngarm, 2009, Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand, New England Journal of Medicine, 361, 2209, 10.1056/NEJMoa0908492 Richman, 2003, Rapid evolution of the neutralizing antibody response to HIV type 1 infection, Proceedings of the National Academy of Sciences of the United States of America, 100, 4144, 10.1073/pnas.0630530100 Rogers, 1989, IgD production and other lymphocyte functions in HIV infection: Immaturity and activation of B cells at different clinical stages, Clinical and Experimental Immunology, 75, 7 Rong, 2007, Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection, Journal of Virology, 81, 1350, 10.1128/JVI.01839-06 Rosa, 2005, Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders, Proceedings of the National Academy of Sciences of the United States of America, 102, 18544, 10.1073/pnas.0509402102 Sainz, 2012, Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor, Nature Medicine, 18, 281, 10.1038/nm.2581 Salam, 2013, Hepatitis C virus NS3 inhibitors: Current and future perspectives, BioMed Research International, 2013, 467869, 10.1155/2013/467869 Sather, 2009, Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection, Journal of Virology, 83, 757, 10.1128/JVI.02036-08 Sattentau, 2014, Immunogen design to focus the B-cell repertoire, Current Opinion in HIV and AIDS, 9, 217, 10.1097/COH.0000000000000054 Scarselli, 2002, The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, 21, 5017, 10.1093/emboj/cdf529 Scheid, 2009, A method for identification of HIV gp140 binding memory B cells in human blood, Journal of Immunological Methods, 343, 65, 10.1016/j.jim.2008.11.012 Scheid, 2011, Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells, Proceedings of the National Academy of Sciences of the United States of America, 108, 18044, 10.1073/pnas.1113395108 Scheid, 2011, Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding, Science, 333, 1633, 10.1126/science.1207227 Scherer, 2007, Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity, AIDS, 21, 2131, 10.1097/QAD.0b013e3282a4a632 Scherzer, 2008, Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C, Journal of Viral Hepatitis, 15, 659, 10.1111/j.1365-2893.2008.01006.x Schmidt, 2014, Direct-acting antiviral agents and the path to interferon independence, Clinical Gastroenterology and Hepatology, 12, 728, 10.1016/j.cgh.2013.06.024 Schofield, 2005, Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, 42, 1055, 10.1002/hep.20906 Shepard, 2005, Global epidemiology of hepatitis C virus infection, The Lancet Infectious Diseases, 5, 558, 10.1016/S1473-3099(05)70216-4 Shimizu, 1994, Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses, Journal of Virology, 68, 1494, 10.1128/JVI.68.3.1494-1500.1994 Shoukry, 2003, Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection, The Journal of Experimental Medicine, 197, 1645, 10.1084/jem.20030239 Simek, 2009, Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm, Journal of Virology, 83, 7337, 10.1128/JVI.00110-09 Simmonds, 2004, Genetic diversity and evolution of hepatitis C virus—15 years on, The Journal of General Virology, 85, 3173, 10.1099/vir.0.80401-0 Simon, 2003, HIV-1 dynamics in vivo: Implications for therapy, Nature Reviews. Microbiology, 1, 181, 10.1038/nrmicro772 Singh, 2011, Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies, AIDS, 25, 1247, 10.1097/QAD.0b013e32834785cf Skokos, 2007, Peptide-MHC potency governs dynamic interactions between T cells and dendritic cells in lymph nodes, Nature Immunology, 8, 835, 10.1038/ni1490 Smith, 2014, Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource, Hepatology, 59, 318, 10.1002/hep.26744 Song, 2003, Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen, Journal of Experimental Medicine, 198, 1923, 10.1084/jem.20031498 Souto-Carneiro, 2004, Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER, Journal of Immunology, 172, 6790, 10.4049/jimmunol.172.11.6790 Stall, 1988, Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals, Proceedings of the National Academy of Sciences of the United States of America, 85, 7312, 10.1073/pnas.85.19.7312 Stamatatos, 2009, Neutralizing antibodies generated during natural HIV-1 infection: Good news for an HIV-1 vaccine?, Nature Medicine, 15, 866, 10.1038/nm.1949 Steinmann, 2013, Cell culture systems for hepatitis C virus, Current Topics in Microbiology and Immunology, 369, 17 Stiegler, 2001, A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1, AIDS Research and Human Retroviruses, 17, 1757, 10.1089/08892220152741450 Sumida, 2013, Characteristics of splenic CD8+ T cell exhaustion in patients with hepatitis C, Clinical and Experimental Immunology, 174, 172, 10.1111/cei.12158 Sun, 2011, Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeys, Journal of Virology, 85, 6906, 10.1128/JVI.00326-11 Szabo, 2008, Hepatitis C and innate immunity: Recent advances, Clinics in Liver Disease, 12, 675, 10.1016/j.cld.2008.03.003 Tangye, 2013, To B1 or not to B1: That really is still the question!, Blood, 121, 5109, 10.1182/blood-2013-05-500074 Tarr, 2007, Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins, Methods in Molecular Biology, 379, 177, 10.1007/978-1-59745-393-6_13 Thimme, 2001, Determinants of viral clearance and persistence during acute hepatitis C virus infection, The Journal of Experimental Medicine, 194, 1395, 10.1084/jem.194.10.1395 Thomas, 2013, Global control of hepatitis C: Where challenge meets opportunity, Nature Medicine, 19, 850, 10.1038/nm.3184 Tiller, 2008, Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning, Journal of Immunological Methods, 329, 112, 10.1016/j.jim.2007.09.017 Tiller, 2007, Autoreactivity in human IgG+ memory B cells, Immunity, 26, 205, 10.1016/j.immuni.2007.01.009 Timpe, 2008, Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies, Hepatology, 47, 17, 10.1002/hep.21959 Tobin, 2008, Deceptive imprinting and immune refocusing in vaccine design, Vaccine, 26, 6189, 10.1016/j.vaccine.2008.09.080 Tomaras, 2008, Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia, Journal of Virology, 82, 12449, 10.1128/JVI.01708-08 Trkola, 1996, Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1, Journal of Virology, 70, 1100, 10.1128/JVI.70.2.1100-1108.1996 van Vollenhoven, 1999, VH4-34 encoded antibodies in systemic lupus erythematosus: A specific diagnostic marker that correlates with clinical disease characteristics, The Journal of Rheumatology, 26, 1727 Vanderlugt, 2002, Epitope spreading in immune-mediated diseases: Implications for immunotherapy, Nature Reviews. Immunology, 2, 85, 10.1038/nri724 Vanwolleghem, 2008, Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain, Hepatology, 47, 1846, 10.1002/hep.22244 Veazey, 1998, Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection, Science, 280, 427, 10.1126/science.280.5362.427 Verkoczy, 2011, Rescue of HIV-1 broad neutralizing antibody-expressing B cells in 2F5 VH x VL knockin mice reveals multiple tolerance controls, Journal of Immunology, 187, 3785, 10.4049/jimmunol.1101633 Verkoczy, 2010, Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance, Proceedings of the National Academy of Sciences of the United States of America, 107, 181, 10.1073/pnas.0912914107 Visentini, 2012, Clonal B cells of HCV-associated mixed cryoglobulinemia patients contain exhausted marginal zone-like and CD21 low cells overexpressing Stra13, European Journal of Immunology, 42, 1468, 10.1002/eji.201142313 Visentini, 2013, Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: The yin and yang of HCV-driven lymphoproliferation and autoimmunity, Autoimmunity Reviews, 12, 430, 10.1016/j.autrev.2012.08.016 Volpe, 2009, Genetic correlates of autoreactivity and autoreactive potential in human Ig heavy chains, Immunome Research, 5, 1, 10.1186/1745-7580-5-1 Wain-Hobson, 1993, The fastest genome evolution ever described: HIV variation in situ, Current Opinion in Genetics and Development, 3, 878, 10.1016/0959-437X(93)90008-D Wakita, 2005, Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, 11, 791, 10.1038/nm1268 Walker, 2010, Adaptive immunity to the hepatitis C virus, Advances in Virus Research, 78, 43, 10.1016/B978-0-12-385032-4.00002-1 Walker, 2011, Broad neutralization coverage of HIV by multiple highly potent antibodies, Nature, 477, 466, 10.1038/nature10373 Wardemann, 2003, Predominant autoantibody production by early human B cell precursors, Science, 301, 1374, 10.1126/science.1086907 Warnatz, 2002, Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: A new approach to classify a heterogeneous disease, Blood, 99, 1544, 10.1182/blood.V99.5.1544 Wehr, 2004, A new CD21low B cell population in the peripheral blood of patients with SLE, Clinical Immunology, 113, 161, 10.1016/j.clim.2004.05.010 Wei, 2007, A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus, Journal of Immunology, 178, 6624, 10.4049/jimmunol.178.10.6624 Wei, 2003, Antibody neutralization and escape by HIV-1, Nature, 422, 307, 10.1038/nature01470 Weiss, 2009, Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area, Journal of Immunology, 183, 2176, 10.4049/jimmunol.0901297 Wen, 2005, Evidence of marginal-zone B cell-positive selection in spleen, Immunity, 23, 297, 10.1016/j.immuni.2005.08.007 West, 2014, Structural insights on the role of antibodies in HIV-1 vaccine and therapy, Cell, 156, 633, 10.1016/j.cell.2014.01.052 Wibmer, 2013, Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes, PLoS Pathogens, 9, e1003738, 10.1371/journal.ppat.1003738 Wilson, 2012, In vitro systems for the study of hepatitis C virus infection, International Journal of Hepatology, 2012, 292591, 10.1155/2012/292591 Wu, 2010, Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1, Science, 329, 856, 10.1126/science.1187659 Wyatt, 1995, Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding, Journal of Virology, 69, 5723, 10.1128/JVI.69.9.5723-5733.1995 Xiao, 2009, Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens, Biochemical and Biophysical Research Communications, 390, 404, 10.1016/j.bbrc.2009.09.029 Xiao, 2010, Multiple vaccine-elicited nonneutralizing antienvelope antibody activities contribute to protective efficacy by reducing both acute and chronic viremia following simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques, Journal of Virology, 84, 7161, 10.1128/JVI.00410-10 Yau, 2014, Hepatitis C drugs: The end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: A concise review, Canadian Journal of Gastroenterology & Hepatology, 28, 445, 10.1155/2014/549624 Yuan, 2011, Putative rhesus macaque germline predecessors of human broadly HIV-neutralizing antibodies: Differences from the human counterparts and implications for HIV-1 vaccine development, Vaccine, 29, 6903, 10.1016/j.vaccine.2011.07.046 Zhang, 1993, Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection, Journal of Virology, 67, 3345, 10.1128/JVI.67.6.3345-3356.1993 Zhang, 2004, Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin, Glycobiology, 14, 1229, 10.1093/glycob/cwh106 Zhang, 2007, Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma, Proceedings of the National Academy of Sciences of the United States of America, 104, 8449, 10.1073/pnas.0703039104 Zhong, 2005, Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences of the United States of America, 102, 9294, 10.1073/pnas.0503596102 Zhou, 2004, Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B, Infection and Immunity, 72, 3505, 10.1128/IAI.72.6.3505-3514.2004 Zignego, 2012, HCV and lymphoproliferation, Clinical and Developmental Immunology, 2012, 980942, 10.1155/2012/980942 Zolla-Pazner, 2011, Cross-clade HIV-1 neutralizing antibodies induced with V3-scaffold protein immunogens following priming with gp120 DNA, Journal of Virology, 85, 9887, 10.1128/JVI.05086-11